Oral delivery product
Latest Pfizer Inc. Patents:
- ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Combination of Talazoparib and an Anti-Androgen for the Treatment of DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer
- Treatment of Breast Cancer with Amcenestrant and Palbociclib
- BENZODIAZEPINES FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS INFECTION
- Calicheamicin derivatives and antibody drug conjugates thereof
Description
Claims
The ornamental design for an oral delivery product, as shown and described.
Referenced Cited
Patent History
Patent number: D748241
Type: Grant
Filed: Oct 21, 2014
Date of Patent: Jan 26, 2016
Assignee: Pfizer Inc. (New York, NY)
Inventor: Michael A. Goode (Powhatan, VA)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Charles Hanson
Application Number: 29/506,865
Type: Grant
Filed: Oct 21, 2014
Date of Patent: Jan 26, 2016
Assignee: Pfizer Inc. (New York, NY)
Inventor: Michael A. Goode (Powhatan, VA)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Charles Hanson
Application Number: 29/506,865
Classifications
Current U.S. Class:
Simulative (2) (D24/102)